These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 7582239

  • 1. Genetic alterations associated with the evolution and progression of astrocytic brain tumours.
    Ohgaki H, Schäuble B, zur Hausen A, von Ammon K, Kleihues P.
    Virchows Arch; 1995; 427(2):113-8. PubMed ID: 7582239
    [Abstract] [Full Text] [Related]

  • 2. Genetic alterations associated with glioma progression.
    Kleihues P, Lübbe J, Watanabe K, von Ammon K, Ohgaki H.
    Verh Dtsch Ges Pathol; 1994; 78():43-7. PubMed ID: 7534015
    [Abstract] [Full Text] [Related]

  • 3. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF, Miller DC, Koslow M, Newcomb EW.
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [Abstract] [Full Text] [Related]

  • 4. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
    Chattopadhyay P, Rathore A, Mathur M, Sarkar C, Mahapatra AK, Sinha S.
    Oncogene; 1997 Aug 14; 15(7):871-4. PubMed ID: 9266974
    [Abstract] [Full Text] [Related]

  • 5. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
    Nozaki M, Tada M, Kobayashi H, Zhang CL, Sawamura Y, Abe H, Ishii N, Van Meir EG.
    Neuro Oncol; 1999 Apr 14; 1(2):124-37. PubMed ID: 11550308
    [Abstract] [Full Text] [Related]

  • 6. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
    Fujisawa H, Kurrer M, Reis RM, Yonekawa Y, Kleihues P, Ohgaki H.
    Am J Pathol; 1999 Aug 14; 155(2):387-94. PubMed ID: 10433932
    [Abstract] [Full Text] [Related]

  • 7. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM.
    Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255
    [Abstract] [Full Text] [Related]

  • 8. [The molecular basis of glia-derived tumours of the brain. Part I].
    Nauman P, Czernicki Z.
    Neurol Neurochir Pol; 2002 Feb 01; 36(3):553-64. PubMed ID: 12185811
    [Abstract] [Full Text] [Related]

  • 9. High-resolution genome-wide allelotype analysis identifies loss of chromosome 14q as a recurrent genetic alteration in astrocytic tumours.
    Hu J, Pang JC, Tong CY, Lau B, Yin XL, Poon WS, Jiang CC, Zhou LF, Ng HK.
    Br J Cancer; 2002 Jul 15; 87(2):218-24. PubMed ID: 12107846
    [Abstract] [Full Text] [Related]

  • 10. Expression and mutation analysis of the p53 gene in astrocytoma.
    Hwang SL, Hong YR, Sy WD, Chai CY, Lin HJ, Howng SL.
    J Formos Med Assoc; 1999 Jan 15; 98(1):31-8. PubMed ID: 10063271
    [Abstract] [Full Text] [Related]

  • 11. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N.
    Neuro Oncol; 2007 Apr 15; 9(2):113-23. PubMed ID: 17327574
    [Abstract] [Full Text] [Related]

  • 12. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
    von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, Kleihues P, Chung RY, Wiestler OD, Seizinger BR.
    Cancer Res; 1992 May 15; 52(10):2987-90. PubMed ID: 1349850
    [Abstract] [Full Text] [Related]

  • 13. Frequency of p53 tumor suppressor gene mutations in human primary brain tumors.
    Wu JK, Ye Z, Darras BT.
    Neurosurgery; 1993 Nov 15; 33(5):824-30; discussion 830-1. PubMed ID: 7903434
    [Abstract] [Full Text] [Related]

  • 14. p53 and PTEN gene mutations in gemistocytic astrocytomas.
    Watanabe K, Peraud A, Gratas C, Wakai S, Kleihues P, Ohgaki H.
    Acta Neuropathol; 1998 Jun 15; 95(6):559-64. PubMed ID: 9650746
    [Abstract] [Full Text] [Related]

  • 15. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H.
    Clin Cancer Res; 1997 Apr 15; 3(4):523-30. PubMed ID: 9815715
    [Abstract] [Full Text] [Related]

  • 16. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
    Ohgaki H, Kleihues P.
    J Neuropathol Exp Neurol; 2005 Jun 15; 64(6):479-89. PubMed ID: 15977639
    [Abstract] [Full Text] [Related]

  • 17. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
    Tada M, Iggo RD, Waridel F, Nozaki M, Matsumoto R, Sawamura Y, Shinohe Y, Ikeda J, Abe H.
    Mol Carcinog; 1997 Mar 15; 18(3):171-6. PubMed ID: 9115587
    [Abstract] [Full Text] [Related]

  • 18. Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas.
    Arslantas A, Artan S, Oner U, Müslümanoglu MH, Ozdemir M, Durmaz R, Arslantas D, Vural M, Cosan E, Atasoy MA.
    Pathol Oncol Res; 2007 Mar 15; 13(1):39-46. PubMed ID: 17387387
    [Abstract] [Full Text] [Related]

  • 19. Role of gemistocytes in astrocytoma progression.
    Watanabe K, Tachibana O, Yonekawa Y, Kleihues P, Ohgaki H.
    Lab Invest; 1997 Feb 15; 76(2):277-84. PubMed ID: 9042164
    [Abstract] [Full Text] [Related]

  • 20. Absence of mutation of the p73 gene in astrocytic neoplasms.
    Alonso ME, Bello MJ, Lomas J, Gonzalez-Gomez P, Arjona D, De Campos JM, Gutierrez M, Isla A, Vaquero J, Rey JA.
    Int J Oncol; 2001 Sep 15; 19(3):609-12. PubMed ID: 11494043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.